Oceania Reg Desk
Wednesday, 2026-10-21 · covering the last 24h
Australia
ASX Listing Rule 7.2 scrip-cap amendments due to commence today — still no confirming Market Notice. The amended Listing Rules and Guidance Notes — narrowing Exceptions 6 and 7 so an S&P/ASX 300 bidder issuing 25% or more of its capital as scrip in a takeover or scheme needs shareholder approval, with new Listing Rule 7.3B letting an entity pre-approve a higher threshold — were slated to take effect Wednesday 21 October "subject to completion of the statutory process." As of this check, ASX's consultations-and-submissions page still shows its 18 September response paper as the latest entry on this item, and no confirming Market Notice has been located on ASX's site or via search. Worth a same-day recheck; the rules may still be in force even without a notice yet visible. ASX consultations and submissions
No other new rulemaking since 20 October. Checked individually: ASIC's newsroom (still renders as an empty JavaScript shell — a failed check, not a quiet day; supplementary search found nothing newer than the 24 Sept CS 63 consultation, comment period open to 5 Nov); the RBA's media-releases page (nothing past the 1 Oct Financial Stability Review and 23 Sept ASX C&S facilities assessment, both already reported; no new FMI rule consultation); TMX Australia Exchange, formerly Cboe Australia (no new market notice); and Treasury's consultation listings (nothing new in scope).
New Zealand
No new rulemaking since 20 October. Checked individually: NZX's rules/guidance channel, which states explicitly there are no upcoming Rule or Guidance changes; the FMA's consultation listing (custody-of-client-assets review unchanged); and the RBNZ's consultations site (the DTA capital-standard risk-weight proposal and retail-payment-system issues paper are unchanged). The RBNZ's prudential-levy consultation closed 16 October but remains out of scope as a bank-supervision cost-recovery matter, not an FMI or equity-market rule.
Informational only — summaries of public regulatory and central bank sources; not advice.